Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients
- 5 September 2002
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 29 (10) , 891-897
- https://doi.org/10.1046/j.1440-1681.2002.03746.x
Abstract
1. The present study was undertaken to compare the effects of a higher dose of policosanol, a cholesterol‐lowering drug, (40 mg/day) with the effects of 20 mg/day policosanol on platelet aggregation ...Keywords
This publication has 36 references indexed in Scilit:
- Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitroBritish Journal of Clinical Pharmacology, 2000
- Efficacy and tolerability of policosanol compared with lovastatin in patients with type II hypercholesterolemia and concomitant coronary risk factorsCurrent Therapeutic Research, 2000
- PolicosanolDrugs of the Future, 2000
- Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factorsClinical Pharmacology & Therapeutics, 1999
- Effects of policosanol on primary hypercholesterolemia: a 3-year open-extension follow-upCurrent Therapeutic Research, 1997
- A comparative study of policosanol versus pravastatin in patients with type II hypercholesterolemiaCurrent Therapeutic Research, 1997
- Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: a 12-month studyCurrent Therapeutic Research, 1995
- Effect of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemiaCurrent Therapeutic Research, 1995
- One-year efficacy and safety of policosanol in patients with type II hypercholesterolemiaCurrent Therapeutic Research, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994